AHA Guidance: Caution Recommended on COVID-19 Treatment with Hydroxychloroquine and Azithromycin for Patients with Cardiovascular Disease

Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment – Circulation

News Release: Caution recommended on COVID-19 treatment with hydroxychloroquine and azithromycin for patients with cardiovascular disease – American Heart Association

Commentaries: Medical groups urge caution when using hydroxychloroquine, azithromycin to treat COVID-19 patients with CVD – Cardiovascular Business AND AHA, ACC, HRS Caution Use of COVID-19 Therapies Hydroxychloroquine and Azithromycin in Cardiac Patients – DAIC